论文部分内容阅读
本文将多阶段复合期权模型应用于某公司的治疗性乙肝疫苗研发项目中,通过计算本文得出结论:即使在临床Ⅰ期和临床Ⅱ期研发都成功的前提下,该公司也不应该投资该项目。
In this paper, the multi-stage compound option model is applied to a company’s therapeutic hepatitis B vaccine research and development project. By calculating the conclusion of this article, the company should not invest even in the successful clinical phase Ⅰ and phase Ⅱ research and development project.